Wanbury Revenue

In the fiscal year ending March 31, 2025, Wanbury had annual revenue of 6.00B INR with 4.15% growth. Wanbury had revenue of 1.72B in the quarter ending March 31, 2025, with 23.38% growth.

Revenue

6.00B

Revenue Growth

+4.15%

P/S Ratio

1.60

Revenue / Employee

4.02M

Employees

1,491

Market Cap

9.62B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	6.00B	238.64M	4.15%
Mar 31, 2024	5.76B	760.03M	15.21%
Mar 31, 2023	5.00B	-115.39M	-2.26%
Mar 31, 2022	5.11B	1.19B	30.23%
Mar 31, 2021	3.93B	250.63M	6.82%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sun Pharmaceutical Industries	525.78B
Divi's Laboratories	93.60B
Cipla	271.45B
Apollo Hospitals Enterprise	217.94B
Mankind Pharma	122.07B
Zydus Lifesciences	232.42B
Aurobindo Pharma	317.24B
Alkem Laboratories	129.65B

Revenue Rankings

Wanbury News

18 days ago - Wanbury receives GMP certification from ANVISA for Patalganga facility - Business Upturn
26 days ago - Wanbury’s Tanuku facility in Andhra Pradesh completes ANVISA inspection with zero observations - Business Upturn
2 months ago - Wanbury launches Wanbury C-RED and Ketamine Hydrochloride - Business Upturn
3 months ago - Wanbury shares rise 2.56% following company refinances Rs 95 crore NCDs, reducing interest costs - Business Upturn
3 months ago - Wanbury secures lower-cost refinancing for outstanding debentures - Business Upturn
5 months ago - Wanbury completes successful ANVISA audit at Tanuku facility - Business Upturn

More News